FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)
NCT ID: NCT03627806
Last Updated: 2021-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
104308 participants
OBSERVATIONAL
2010-01-01
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GLORIA-AF Registry Program - Second and Third Phases
NCT01468701
Atrial Fibrillation Screening and Education Study
NCT03440762
GLORIA-AF Registry Program (Phase I)
NCT01428765
Stroke Prevention and Rhythm Control Therapy STEEER-AF
NCT04396418
Atrial Fibrillation in Relationship to Plasma Biomarkers
NCT04710745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* primary diagnosis of ischemic stroke
* enrolled in the Florida - Puerto Rico Stroke Registry
Exclusion Criteria
* diagnosis of subarachnoid hemorrhage
* stroke not otherwise specified
* no stroke related diagnosis
* admission for elective carotid intervention only
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tatjana Rundek, MD, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tatjana Rundek, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sur NB, Wang K, Di Tullio MR, Gutierrez CM, Dong C, Koch S, Gardener H, Garcia-Rivera EJ, Zevallos JC, Burgin WS, Rose DZ, Goldberger JJ, Romano JG, Sacco RL, Rundek T. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation. Stroke. 2019 Jun;50(6):1452-1459. doi: 10.1161/STROKEAHA.118.023959. Epub 2019 May 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CV185-564
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.